Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Bennett

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Blood|September 23, 2010
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupMartin S Tallman, Haesook T Kim, Pau Montesinos, et al.
Leukemia|November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasmsMrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Haematologica|May 4, 2019
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditionsPeter Valent, Attilio Orazi, Michael R Savona, et al.
Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Leukemia Research|September 17, 2018
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDSYasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, et al.
Blood|June 24, 2016
Time-dependent changes in mortality and transformation risk in MDSMichael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, et al.
Blood|June 29, 2012
Revised international prognostic scoring system for myelodysplastic syndromesPeter L Greenberg, Heinz Tuechler, Julie Schanz, et al.
Blood|August 19, 2016
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromesPeter L Greenberg, Heinz Tuechler, Julie Schanz, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Blood|September 23, 2010
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA GroupMartin S Tallman, Haesook T Kim, Pau Montesinos, et al.
Leukemia|November 6, 2022
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasmsMrinal M Patnaik, Amer M Zeidan, Eric Padron, et al.
Haematologica|May 4, 2019
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditionsPeter Valent, Attilio Orazi, Michael R Savona, et al.
Haematologica|October 26, 2014
Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control groupFriederike Braulke, Uwe Platzbecker, Catharina Müller-Thomas, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Myelodysplastic syndromes, version 2.2015Peter L Greenberg, Richard M Stone, Rafael Bejar, et al.
Leukemia Research|September 17, 2018
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDSYasushi Miyazaki, Heinz Tuechler, Guillermo Sanz, et al.
Blood|June 24, 2016
Time-dependent changes in mortality and transformation risk in MDSMichael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz, et al.
Blood|June 29, 2012
Revised international prognostic scoring system for myelodysplastic syndromesPeter L Greenberg, Heinz Tuechler, Julie Schanz, et al.
Blood|August 19, 2016
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromesPeter L Greenberg, Heinz Tuechler, Julie Schanz, et al.
Pageof 17